Opposition to the Affordable Care Act has dropped by seven percentage points since early January, before Donald Trump became president. » Read More
A Republican push to repeal and replace Obamacare has slowed amid concerns over large numbers of people losing health coverage. » Read More
Shkreli is accused of ripping off his former pharma company Retrophin to pay off hedge-fund investors he was accused of defrauding. » Read More
By: Rachel Cao
Shares of Bristol-Myers climbed as much as 4 percent after billionaire Carl Icahn reportedly took a stake in the company, according to Dow Jones. » Read More
About 10 percent of the population could lose access to individual health plans under a "repeal-and-delay" bill.
The pace of enrollment in the final two weeks of the sign-up season was sharply lower than the pace seen last year.
Senator Klobuchar wants drugmaker Kaleo to explain the $4,500 price tags on its autoinjector devices for opioid overdose and food allergies.
CNBC's Meg Tirrell tries out Quest Diagnostics' Blueprint for Athletes blood test.
President Donald Trump has said he wants to repeal and replace the Affordable Care Act soon.
Joshua Peck estimates that nearly 500,000 fewer people enrolled in Obamacare because ads and outreach were dramatically scaled back.
The effort to repeal the Affordable Care Act is meeting resistance from a number of Americans concerned about people becoming uninsured.
Dr. Suha Abushhamma was sent back to Saudia Arabia on Saturday after a judge issued an order staying ejections of people like her.
Night owls may be able to get to bed earlier just by taking more weekend camping trips, according to new research.
There are buying opportunities in biotech and drug stocks despite the backlash from the repeal of Obamacare.
Bank of America predicts Amgen shares could rally 23 percent in the next 12 months.
More than 11.6 million people had signed up by mid-January for Obamacare plans sold on government marketplaces.
Aetna Chief Mark Bertolini also said the insurer is weighing its options after a judge blocked its proposed $37 billion merger with Humana.
"We have to get the prices down," Trump tells drugmakers at the White House.
The No. 3 U.S. health insurer's total revenue rose about 5 percent to $15.73 billion but was below expectations.
Mylan has been under fire since last summer over the rising price of its anti-allergy auto-injector EpiPen device.
Public support for the Affordable Care Act increased by 6 percentage points, as Republicans move toward repealing the law.
The Cleveland Clinic has held a fundraiser at Trump's Mar-A-Lago resort every year since 2011.
Millions of Americans have an abnormal heart rhythm, or cardiac arrhythmia, but monitoring these cases can be cumbersome.
You have until Jan. 31 to buy medical coverage on the state and federal marketplaces.
Get the best of CNBC in your inbox